Author Archives: Helena Bonner

CSM researchers and collaborators discover that high chromosomal instability may predict which patients will benefit most from colorectal cancer drug

Research aims to make sure that patients only receive drugs that will work specifically for their own disease Wednesday, 10 October 2018: Researchers at RCSI/CSM, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability  (where … Continue reading

Posted in News | Comments Off on CSM researchers and collaborators discover that high chromosomal instability may predict which patients will benefit most from colorectal cancer drug

TY programme 2019- Applications now open

TY-programme-Application-form (1)

Posted in News | Comments Off on TY programme 2019- Applications now open

CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug

Scientists discover predictive biomarker for key colorectal cancer drug Friday, 01 June 2018: The ANGIOPREDICT research consortium have discovered a potential biomarker that can predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin). … Continue reading

Posted in News | Comments Off on CSM Researchers and collaborators discover predictive biomarker for key colorectal cancer drug

MSc students from the Netherlands visit the CSM

Monday 30th April 34 students and 2 professors from Radboud University Nijmegen (the Netherlands)  visited RCSI and the CSM labs. They were welcomed by Prof. Prehn and Dr Helena Bonner and spent the day listening to presentations on the research … Continue reading

Posted in News | Comments Off on MSc students from the Netherlands visit the CSM

Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22!

Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22! (doi:10.1093/bioinformatics/btw660)

Posted in News | Comments Off on Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22!

PurinesDX conference April 24th RCSI

The PurinesDX consortium (coordinated by Dr Tobias Engel, RCSI) will be hosting its first meeting on April 24th 2018 at the Cheyne Lecture Theatre – see programme attached! Registration (free) at purinesdx@rcsi.ie.   PurinesDX Mini-symposium 24 April 2018

Posted in News | Comments Off on PurinesDX conference April 24th RCSI

‘Breast-Predict’ have developed a tool that may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.

Irish scientists raise new hope in fight against aggressive breast cancer Doctors may soon be able to spare some cancer patients the harsh effects of chemotherapy. Researchers from RCSI and the Irish Cancer Society research centre ‘Breast-Predict’ have developed a … Continue reading

Posted in News | Comments Off on ‘Breast-Predict’ have developed a tool that may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.

GLIOTRAIN : European Training Network PhD Student Position available

Applications are invited from candidates of excellence wishing to pursue a PhD degree in the field of cancer precision medicine. Students will receive training within a pan-European academic/privatesector research training network, specifically focused on brain tumour research. Closing date for … Continue reading

Posted in News | Comments Off on GLIOTRAIN : European Training Network PhD Student Position available

CoEN Award to CSM-Network of Centres of Excellence in Neurodegeneration

Title of project: Carbon-Model: Carbon metabolism systems analysis for the identification of disease and patient-specific metabolic and energetic defects in neurodegenerative diseases awarded to Prof. Jochen Prehn and Co-applicants: Dr. Niamh Connolly and Dr. Simon Furney, CSM, RCSI and Daniele Bano, … Continue reading

Posted in News | Comments Off on CoEN Award to CSM-Network of Centres of Excellence in Neurodegeneration

GLIOTRAIN, Brain Tumor Ireland and RCSI Presents Two Public Lectures- Friday March 9th

Prof Annette Byrne, GLIOTRAIN Coordinator is taking part in this joint event on 9th March organised by Brain Tumour Ireland and RCSI, as part of Brain Awareness Week 2018. The two lectures are open to the public and are free, … Continue reading

Posted in News | Comments Off on GLIOTRAIN, Brain Tumor Ireland and RCSI Presents Two Public Lectures- Friday March 9th